|Bid||203.05 x 0|
|Ask||203.15 x 0|
|Day's Range||198.76 - 205.25|
|52 Week Range||111.83 - 219.60|
|Beta (5Y Monthly)||1.50|
|PE Ratio (TTM)||6.46|
|Forward Dividend & Yield||0.03 (1.53%)|
|Ex-Dividend Date||Aug 12, 2021|
|1y Target Est||N/A|
(Bloomberg) -- The collapse of an $8 billion biotech acquisition and a slump in the Swedish krona left Barclays Plc with a major loss last month. Most Read from BloombergA Nor’easter Approaching New York Risks Becoming a Bomb CycloneStock Rebound Fails and Futures Plunge on Earnings: Markets WrapMark Zuckerberg’s Stablecoin Ambitions Unravel With Diem Sale TalksAstronomers Spot Never-Before Seen Object at 4,000 Light-Years AwayNvidia Quietly Prepares to Abandon $40 Billion Arm BidThe London-base
Investment company S.E.E.D. Planning Group LLC (Current Portfolio) buys Honeywell International Inc, Medtronic PLC, Johnson & Johnson, Walmart Inc, Barclays PLC, sells Clorox Co, Target Corp, Northrop Grumman Corp, The GEO Group Inc, Corsair Gaming Inc during the 3-months ended 2021Q4, according to the most recent filings of the investment company, S.E.E.D.
JPMorgan, Barclays and Deutsche Bank have told staff they can return to the office in England, joining a growing number of banks reopening their buildings after COVID-19 restrictions were eased this week. JPMorgan told staff in England to return from Feb. 1, adding they expected people to work at least some days in the office every week according to working patterns agreed within teams, an internal memo seen by Reuters said. Deutsche Bank has told employees they can start coming back to the office from Jan. 31, a spokesperson said.